COVID-19
COVID-19 Diagnostics
COVID-19 Management & Therapeutics

This algorithm is intended to help clinicians at the point of care initiate oral antiviral treatment for COVID-19. Based on efficacy data, nirmatrelvir/ritonavir (NMV/r) is the preferred agent, followed by molnupiravir.

The algorithm was created by USAID Implementing partners EpIC, RISE, STAR-UCSF.

L1
L2
L3

Think we are missing something?

Menu